29050336|t|Transcriptional downregulation of microRNA-19a by ROS production and NF-kappaB deactivation governs resistance to oxidative stress-initiated apoptosis.
29050336|a|Cell apoptosis is one of the main pathological alterations during oxidative stress (OS) injury. Previously, we corroborated that nuclear factor-kappaB (NF-kappaB) transactivation confers apoptosis resistance against OS in mammalian cells, yet the underlying mechanisms remain enigmatic. Here we report that microRNA-19a (miR-19a) transcriptionally regulated by reactive oxygen species (ROS) production and NF-kappaB deactivation prevents OS-initiated cell apoptosis through cylindromatosis (CYLD) repression. CYLD contributes to OS-initiated cell apoptosis, for which NF-kappaB deactivation is essential. MiR-19a directly represses CYLD via targeting 3' UTR of CYLD, thereby antagonizing OS-initiated apoptosis. CYLD repression by miR-19a restores the IKKbeta phosphorylation, RelA disassociation from IkappaBalpha, IkappaBalpha polyubiquitination and degradation, RelA recruitment at VEGF gene promoter as well as VEGF secretion in the context of OS. Either pharmacological deactivation of NF-kappaB or genetic upregulation of CYLD compromises the apoptosis-resistant phenotypes of miR-19a. Furthermore, miR-19a is transcriptionally downregulated upon OS in two distinct processes that require ROS production and NF-kappaB deactivation. VEGF potentiates the ability of miR-19a to activate NF-kappaB and render apoptosis resistance. Our findings underscore a putative mechanism whereby CYLD repression-mediated and NF-kappaB transactivation-dependent miR-19a regulatory feedback loop prevents cell apoptosis in response to OS microenvironment.
29050336	34	46	microRNA-19a	Gene	406979
29050336	50	53	ROS	Chemical	MESH:D017382
29050336	69	78	NF-kappaB	Gene	4790
29050336	281	302	nuclear factor-kappaB	Gene	4790
29050336	304	313	NF-kappaB	Gene	4790
29050336	459	471	microRNA-19a	Gene	406979
29050336	473	480	miR-19a	Gene	406979
29050336	513	536	reactive oxygen species	Chemical	MESH:D017382
29050336	538	541	ROS	Chemical	MESH:D017382
29050336	558	567	NF-kappaB	Gene	4790
29050336	626	641	cylindromatosis	Disease	MESH:C536611
29050336	643	647	CYLD	Disease	MESH:C536611
29050336	661	665	CYLD	Disease	MESH:C536611
29050336	720	729	NF-kappaB	Gene	4790
29050336	757	764	MiR-19a	Gene	406979
29050336	784	788	CYLD	Disease	MESH:C536611
29050336	813	817	CYLD	Disease	MESH:C536611
29050336	864	868	CYLD	Disease	MESH:C536611
29050336	883	890	miR-19a	Gene	406979
29050336	904	911	IKKbeta	Gene	3551
29050336	929	933	RelA	Gene	5970
29050336	954	966	IkappaBalpha	Gene	4792
29050336	968	980	IkappaBalpha	Gene	4792
29050336	1017	1021	RelA	Gene	5970
29050336	1037	1041	VEGF	Gene	7422
29050336	1067	1071	VEGF	Gene	7422
29050336	1143	1152	NF-kappaB	Gene	4790
29050336	1180	1184	CYLD	Disease	MESH:C536611
29050336	1235	1242	miR-19a	Gene	406979
29050336	1257	1264	miR-19a	Gene	406979
29050336	1347	1350	ROS	Chemical	MESH:D017382
29050336	1366	1375	NF-kappaB	Gene	4790
29050336	1390	1394	VEGF	Gene	7422
29050336	1422	1429	miR-19a	Gene	406979
29050336	1442	1451	NF-kappaB	Gene	4790
29050336	1538	1542	CYLD	Disease	MESH:C536611
29050336	1567	1576	NF-kappaB	Gene	4790
29050336	1603	1610	miR-19a	Gene	406979
29050336	Association	406979	5970
29050336	Association	406979	7422
29050336	Association	MESH:C536611	3551
29050336	Association	4792	5970
29050336	Negative_Correlation	MESH:D017382	MESH:C536611
29050336	Association	MESH:C536611	4790
29050336	Positive_Correlation	4790	7422
29050336	Association	3551	406979
29050336	Association	MESH:C536611	4792
29050336	Association	406979	4790
29050336	Positive_Correlation	5970	7422
29050336	Association	MESH:C536611	5970
29050336	Negative_Correlation	MESH:D017382	406979
29050336	Negative_Correlation	MESH:C536611	406979
29050336	Association	MESH:C536611	7422
29050336	Association	406979	4792

